Seoul, South Korea

Seon Yeong Lee

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: The Catholic University of Korea, Bifido Co., Ltd.. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seon Yeong Lee. Retrieved from https://idiyas.com/inventor/seon-yeong-lee-rt3lglvs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 12.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Seon Yeong Lee: A Closer Look at His Work

Introduction: Seon Yeong Lee is a prominent inventor based in Seoul, South Korea. With a significant contribution to the field of medical research, he has been awarded two patents focused on innovative solutions for treating complex health conditions. His work reflects a commitment to enhancing patient care and advancing medical treatments.

Latest Patents: Seon Yeong Lee's latest patents highlight his dedication to addressing serious health issues. The first patent involves the development of a RAPO strain (Accession No.: KCTC 13773BP), which is designed to alleviate, treat, or prevent rheumatoid arthritis. This novel strain and its corresponding composition aim to improve patient outcomes in managing this chronic condition.

The second patent provides a composition for alleviating nephrotoxicity caused by immunosuppressive drugs, incorporating metformin. This composition seeks to enhance the treatment of diseases that require immunosuppression by mitigating renal function decline, often a side effect of conventional immunosuppressive drugs. Moreover, it’s applicable in preventing or treating organ transplant rejection, autoimmune diseases, and inflammatory diseases by offering effective co-administration methods.

Career Highlights: Seon Yeong Lee has made significant strides in his career working primarily with The Catholic University of Korea and its Industry-Academic Cooperation Foundation. His research contributions have supported the development of groundbreaking medical compositions and treatments, showcasing the impact of his innovative thinking.

Collaborations: Collaboration has played a crucial role in Lee's research endeavors. He has worked alongside notable colleagues, such as Mi La Cho and Sung Hwan Park, enhancing the depth and breadth of his work through teamwork and shared expertise.

Conclusion: In conclusion, Seon Yeong Lee stands out as an inventive force in the medical research landscape. With two significant patents to his name, his work focuses on alleviating serious health conditions like rheumatoid arthritis and nephrotoxicity. His dedication to innovation and collaboration continues to pave the way for advancements in medical treatment and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…